BCKDK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BCKDK monoclonal antibodies for investigating branched-chain keto acid dehydrogenase kinase (BCKDK) in biological processes. BCKDK monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BCKDK is a key enzyme that regulates branched-chain amino acid metabolism, playing an essential role in energy homeostasis and cellular signaling pathways. Research has shown that BCKDK dysregulation is associated with metabolic disorders and various types of cancer, highlighting its importance as a therapeutic target. BCKDK studies have revealed significant implications for understanding metabolic regulation and disease mechanisms. Ongoing research continues to uncover new functions of BCKDK in cellular processes and disease development. Advanced detection methods enable precise visualization and quantification of BCKDK expression patterns across different tissues and experimental conditions. Santa Cruz Biotechnology monoclonal antibodies for BCKDK research contribute to advancing scientific knowledge in metabolism and disease research, supporting breakthrough discoveries in the scientific community.